Zhang Y, Liu D, Zhang Z, Huang X, et al. Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report. J Neurol 2024 Apr 11. doi: 10.1007/s00415-024-12367.
PMID: 38602546